KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Thermo Fisher Scientific (TMO) over the last 17 years, with Q3 2025 value amounting to $1.9 billion.

  • Thermo Fisher Scientific's Accumulated Expenses rose 334.61% to $1.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 billion, marking a year-over-year increase of 334.61%. This contributed to the annual value of $2.0 billion for FY2024, which is 2456.14% up from last year.
  • Latest data reveals that Thermo Fisher Scientific reported Accumulated Expenses of $1.9 billion as of Q3 2025, which was up 334.61% from $1.5 billion recorded in Q2 2025.
  • In the past 5 years, Thermo Fisher Scientific's Accumulated Expenses registered a high of $2.4 billion during Q4 2021, and its lowest value of $1.3 billion during Q2 2023.
  • Over the past 5 years, Thermo Fisher Scientific's median Accumulated Expenses value was $1.6 billion (recorded in 2023), while the average stood at $1.7 billion.
  • Its Accumulated Expenses has fluctuated over the past 5 years, first skyrocketed by 7403.97% in 2021, then crashed by 2392.57% in 2023.
  • Thermo Fisher Scientific's Accumulated Expenses (Quarter) stood at $2.4 billion in 2021, then fell by 13.68% to $2.1 billion in 2022, then fell by 23.82% to $1.6 billion in 2023, then rose by 24.56% to $2.0 billion in 2024, then dropped by 5.23% to $1.9 billion in 2025.
  • Its Accumulated Expenses was $1.9 billion in Q3 2025, compared to $1.5 billion in Q2 2025 and $1.4 billion in Q1 2025.